Celentyx is a CRO offering bespoke assay services in human immunology, including immuno-oncology, autoimmunity & inflammation, fibrosis.
Celentyx Ltd is a CRO offering bespoke assay services in human immunology, including immuno-oncology, autoimmunity & inflammation, fibrosis and neuroinflammation.Drawing on the World-leading expertise of Celentyx personnel, along with our close association with the MRC Centre for Immune Regulation and the Centre for Translational Inflammation Research enables the human immune system in health and disease to be investigated at the highest levels of resolution.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 12, 2007 | Seed | — | 1 | Mercia Fund Managers | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Mercia Fund Managers | Yes | Seed |